Education
About Us
Working with TipRanks
Follow Us
FitLife Brands (FTLF)
NASDAQ:FTLF
Top Page
FitLife Brands
(NASDAQ:FTLF)
74Outperform
Positive Factors
Earnings Performance
Earnings growth significantly outpaced revenue growth, with EPS rising 40% to $0.21.
Market Position
FitLife's unique position executing a roll-up strategy in the fragmented supplement industry offers a compelling opportunity for investors.
Revenue Growth
Revenue grew 13% year-over-year to $15.0M, driven by strong online sales and contributions from recently acquired brands.
Negative Factors
Share Price Concerns
Despite significant share price growth, further multiple expansion can be supported by growth in existing brands and expanding the portfolio with new brands.
FitLife Brands (FTLF) vs. S&P 500 (SPY)
Market Cap
$116.25M
Dividend YieldN/A
Average Volume (3M)12.86K
Price to Earnings (P/E)13.7
Beta (1Y)0.27
Revenue Growth22.33%
EPS Growth65.30%
CountryUS
Employees37
SectorConsumer Defensive
Sector Strength73
IndustryPackaged Foods
Share Statistics
EPS (TTM)0.92
Shares Outstanding9,218,528
10 Day Avg. Volume12,511
30 Day Avg. Volume12,864
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)N/A
Price to Sales (P/S)1.98
Price to Cash Flow (P/CF)15.20
P/FCF Ratio15.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$20.50Price Target Upside62.57% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
FitLife Brands Business Overview & Revenue Model
Company DescriptionFitLife Brands, Inc. (FTLF) is a leading provider of innovative and proprietary nutritional supplements and wellness products. The company caters primarily to health-conscious consumers seeking to improve their fitness and overall well-being. FitLife Brands operates in the health and wellness sector, offering a diverse range of products under multiple brands, including sports nutrition supplements, energy products, and weight management solutions.
How the Company Makes MoneyFitLife Brands generates revenue through the sale of its nutritional supplements and wellness products. The company's primary revenue streams include direct sales to consumers through online platforms and wholesale distribution to various retail partners, including specialty health stores and fitness centers. FitLife Brands also engages in strategic partnerships and collaborations with key industry players to expand its market reach and enhance its product offerings. Additionally, the company invests in marketing and brand-building initiatives to drive consumer engagement and increase sales.
FitLife Brands Financial Statement Overview
Summary
FitLife Brands demonstrates strong financial performance with notable revenue growth and efficient cost management. The company shows consistent profitability and growth, supported by strong margins and effective cash flow management, although there is a slight increase in total debt.Income Statement
FitLife Brands demonstrates strong financial performance with notable revenue growth of 19.07% in TTM (Trailing-Twelve-Months) compared to last year, reflecting robust demand. The gross profit margin at 43.30% and the net profit margin at 13.38% indicate efficient cost management and profitability. EBIT and EBITDA margins of 19.61% and 20.20% respectively further highlight operational efficiency. These metrics underscore a trend of consistent profitability and growth, enhancing the company's financial health.85
Very Positive
Balance Sheet
The balance sheet reveals a solid financial structure with a debt-to-equity ratio of 0.43, suggesting moderate leverage and manageable debt levels. The return on equity (ROE) of 24.57% showcases effective utilization of equity in generating profits. An equity ratio of 58.29% signifies a strong equity position relative to total assets, indicating financial stability. However, the increase in total debt over the previous year slightly tempers the otherwise strong balance sheet metrics.78
Positive
Cash Flow
FitLife Brands exhibits impressive cash flow management, with a significant free cash flow growth rate of 144.13% in TTM. The operating cash flow to net income ratio of 1.20 and a free cash flow to net income ratio of 1.20 indicate efficient conversion of income into cash, supporting liquidity and operational flexibility. These factors demonstrate strong cash-generating capability, crucial for sustaining growth and funding potential investments.80
Positive
| Breakdown | |||||
| TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 62.76M | 52.70M | 28.80M | 27.90M | 21.74M | 19.50M | Gross Profit |
| 27.16M | 21.43M | 12.03M | 12.49M | 9.39M | 8.06M | EBIT |
| 12.30M | 7.55M | 5.70M | 6.22M | 4.20M | 2.58M | EBITDA |
| 12.68M | 8.12M | 5.89M | 6.81M | 4.38M | 2.80M | Net Income Common Stockholders |
| 8.39M | 5.30M | 4.43M | 5.41M | 8.82M | 2.70M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 259.00K | 1.14M | 13.28M | 9.90M | 6.34M | 265.00K | Total Assets |
| 5.86M | 55.35M | 25.71M | 21.48M | 16.77M | 6.33M | Total Debt |
| 500.00K | 20.15M | 103.00K | 158.00K | 661.00K | 254.00K | Net Debt |
| 241.00K | 19.01M | -13.17M | -9.74M | -5.67M | -11.00K | Total Liabilities |
| 3.55M | 28.31M | 4.32M | 4.19M | 4.74M | 2.98M | Stockholders Equity |
| 2.31M | 27.04M | 21.39M | 17.29M | 12.03M | 3.34M |
| Cash Flow | Free Cash Flow | ||||
| 10.04M | 4.11M | 4.13M | 4.48M | 5.72M | 2.26M | Operating Cash Flow |
| 10.10M | 4.22M | 4.13M | 4.48M | 5.72M | 2.26M | Investing Cash Flow |
| -17.02M | -35.99M | 0.00 | -529.00K | 0.00 | 0.00 | Financing Cash Flow |
| 3.17M | 20.30M | -750.00K | -390.00K | 350.00K | -2.25M |
FitLife Brands Technical Analysis
Negative
12.61
Price Trends
14.82
Negative
15.49
Negative
15.78
Negative
Market Momentum
-0.51
Positive
33.94
Neutral
31.37
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FTLF, the sentiment is Negative. The current price of 12.61 is below the 20-day moving average (MA) of 13.87, below the 50-day MA of 14.82, and below the 200-day MA of 15.78, indicating a bearish trend. The MACD of -0.51 indicates Positive momentum. The RSI at 33.94 is Neutral, neither overbought nor oversold. The STOCH value of 31.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FTLF.
FitLife Brands Risk Analysis
FitLife Brands disclosed 25 risk factors in its most recent earnings report. FitLife Brands reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
FitLife Brands Peers Comparison
Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | $6.20B | 14.75 | 16.03% | 2.00% | 4.07% | 1110.92% | |
74 Outperform | $116.25M | 13.72 | 28.45% | ― | 22.33% | 65.30% | |
70 Outperform | $233.82M | 31.31 | 4.98% | ― | 2.03% | -47.76% | |
66 Neutral | $867.26M | 3.43 | -31.74% | ― | -1.37% | 75.47% | |
66 Neutral | $525.17M | 12.68 | 7.76% | ― | -7.22% | -33.67% | |
63 Neutral | $20.68B | 14.36 | -12.41% | 3.14% | 1.24% | 2.53% | |
55 Neutral | $151.27M | 73.10 | 1.02% | ― | -43.80% | -97.89% |
* Consumer Defensive Sector Average
Performance Comparison
FTLF
FitLife Brands
12.61
0.36
2.94%
HLF
Herbalife
8.57
-0.54
-5.93%
MED
Medifast
13.83
-23.68
-63.13%
NATR
Nature's Sunshine Products
12.65
-8.22
-39.39%
THG
Hanover Insurance
172.63
41.90
32.05%
USNA
USANA Health
27.78
-20.18
-42.08%
FitLife Brands Earnings Call Summary
Earnings Call Date: Mar 27, 2025 | % Change Since: -9.41% | Next Earnings Date: May 14, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted strong overall financial performance for 2024, with significant growth in revenue, profit, and online sales. However, challenges were noted in the Legacy FitLife segment, mainly due to a dispute with GNC, and expected declines in MRC revenues for Q1 2025, which balance the positive achievements.Highlights
Significant Revenue and Profit Growth
For the full year 2024, total revenue increased 22% year-over-year to $64.5 million. Gross profit increased 31%, and gross margin expanded from 40.7% to 43.6%. Net income increased 70% to $9 million.
Impressive Online Sales Performance
Online sales grew 29% year-over-year and represented 67% of the Company's total revenue.
Robust Adjusted EBITDA Growth
Adjusted EBITDA for the full year increased 39% to $14.1 million.
Mimi's Rock Contribution Growth
MRC's gross margin increased year-over-year from 40.4% to 48.7%, and contribution as a percentage of revenue increased from 28.2% to 37.1%.
MusclePharm Brand Developments
Launch of the new MusclePharm Pro Series, including nine SKUs in a Vitamin Shoppe pilot, and introduction of new flavors in protein bars and ready-to-drink proteins.
Lowlights
Legacy FitLife Revenue Decline
Total Legacy FitLife revenue for Q4 2024 was $5.3 million, representing a 13% year-over-year decline. Wholesale revenue declined 20%, and online revenue declined 1%.
Commercial Dispute with GNC
A dispute with the largest customer, GNC, led to a halt in order acceptance from December 1, 2024, through January 23, 2025, affecting sales.
Challenges with MRC Skin Care Brands
Revenue for the skin care brands declined 38% in Q4 2024 due to unprofitable revenue rationalization.
Expected Revenue Decline in Q1 2025
Consolidated revenue for Q1 2025 is estimated to be 4% to 6% lower than Q1 2024, mainly due to tough comparisons with MRC's strong performance in early 2024.
Company Guidance
During the FitLife Brands Fourth Quarter 2024 earnings call, CEO Dayton Judd reported a 22% year-over-year increase in total revenue, reaching $64.5 million, with online sales growing 29% and contributing 67% of total revenue. The company achieved a gross profit increase of 31%, expanding the gross margin from 40.7% to 43.6%. Contribution surged by 37% to $23.5 million. Net income rose 70% to $9 million, with basic EPS up 66% to $0.98 and fully diluted EPS up 69% to $0.91. Adjusted EBITDA increased 39% to $14.1 million. For the fourth quarter, total revenue grew 13% to $15 million, with online revenue up 12% to $10.1 million. Gross profit increased 16% to $6.2 million, and gross margin expanded to 41.4%. The company ended the year with $13.1 million outstanding on term loans, $4.5 million in cash, and no balance on its revolving line of credit, resulting in a net debt of $8.6 million. Judd also discussed a commercial dispute with GNC, which was resolved in January 2025, and highlighted ongoing efforts to optimize brand performance and navigate tariff impacts.FitLife Brands Corporate Events
M&A TransactionsBusiness Operations and StrategyFinancial Disclosures
FitLife Brands Reports Strong 2024 Financial Performance
Positive
Mar 27, 2025
FitLife Brands reported a strong financial performance for the fourth quarter and full year of 2024, with total revenue for the year increasing by 22% to $64.5 million and net income rising by 70% to $9.0 million. The company’s online sales, which accounted for 67% of total revenue, grew by 29% over the year, while acquisitions of Mimi’s Rock Corp and MusclePharm assets contributed significantly to wholesale revenue. The improved financial results reflect FitLife’s strategic focus on expanding its market presence and enhancing profitability, positioning the company favorably within the nutritional supplements industry.
Business Operations and StrategyFinancial Disclosures
FitLife Brands Projects Strong Financial Growth for 2024
Positive
Mar 13, 2025
On March 13, 2025, FitLife Brands announced its participation in the 37th Annual Roth Conference scheduled for March 17-18, 2025, and provided a financial and operational update. The company anticipates a significant increase in its financial performance for the full year 2024, with net revenue expected to rise by 21-23%, adjusted EBITDA by 38-40%, and net income by 68-72% compared to 2023. As of December 31, 2024, FitLife had $13.1 million outstanding on its term loan and $4.5 million in cash, with no balance on its revolver.
Stock Split
FitLife Brands Announces 2-for-1 Stock Split
Positive
Feb 5, 2025
On February 5, 2025, FitLife Brands announced a 2-for-1 forward stock split of its common stock, which will take effect on February 6, 2025, with trading on a split-adjusted basis starting February 7, 2025, on the Nasdaq Capital Market. This move, approved by the Board of Directors without requiring stockholder approval, aims to increase the stock’s daily trading volumes and make it more accessible to a broader range of investors. The forward split doubles the number of outstanding shares from 4.6 million to 9.2 million but does not alter stockholders’ percentage ownership or voting power.
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.